Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06931301 · ClinicalTrials.gov registry record · NA
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT06931301: Clinical Trial NA study, sponsored by Yale University.
NCT06931301 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06931301, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine whether the Hyperbaric Oxygen Therapy (HBOT) conducted under the Marx Protocol improves pain outcomes when combined with core decompression with autologous bone marrow aspirate concentrate to treat patients with femoral head avascular necrosis.
Primary Outcome
Participants will be asked to mark a point on a 100 mm horizontal line that represents the intensity of their pain. This line has two endpoints: 0: No pain and 10: Worst possible pain imaginable. The distance from the "0" to the mark is measured in millimeters with the resulting number (0-10) being the VAS pain score.
Interventions
- DEVICE Hyperbaric Oxygen Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2026-12 |
| Est. Completion | 2035-04 |
| Phase | NA |
What is known before NCT06931301 opens enrollment
NCT06931301 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric Oxygen Therapy is the first listed.
NCT06931301 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06931301 about?
NCT06931301 is a clinical study titled "Effect of HBOT on Femoral Head Avascular Necrosis (AVN)". The primary objective of this study is to determine whether the Hyperbaric Oxygen Therapy (HBOT) conducted under the Marx Protocol improves pain outcomes when combined with core decompression with autologous bone marrow aspirate concentrate to treat patients with femoral head avascular necrosis.
What is the current status of trial NCT06931301?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2026-12. Estimated completion is 2035-04.
What interventions are being tested in trial NCT06931301?
The interventions under investigation include: Hyperbaric Oxygen Therapy (DEVICE).
Who is sponsoring clinical trial NCT06931301?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06931301's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia